Australia markets open in 4 hours 49 minutes

Cogent Biosciences, Inc. (COGT)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
7.81+0.21 (+2.76%)
As of 03:11PM EDT. Market open.
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
0
0
0
0
7,871
Operating expenses
Research development
105,399
173,755
121,627
55,913
25,738
Selling general and administrative
24,335
34,375
26,212
19,638
17,422
Total operating expenses
129,734
208,130
147,839
75,551
43,160
Operating income or loss
-129,734
-208,130
-147,839
-75,551
-35,289
Total other income/expenses net
2,213
2,643
3,609
2,811
-39,663
Income before tax
-125,535
-192,410
-140,241
-72,273
-74,808
Income from continuing operations
-125,535
-192,410
-140,241
-72,273
-74,808
Net income
-125,535
-192,410
-140,241
-72,273
-74,808
Net income available to common shareholders
-125,535
-192,410
-140,241
-72,273
-179,208
Basic EPS
-2.34
-
-2.39
-1.65
-16.17
Diluted EPS
-2.34
-
-2.39
-1.65
-16.17
Basic average shares
75,611
-
58,740
43,806
11,081
Diluted average shares
75,611
-
58,740
43,806
11,081